Software Expands Plant-Specific Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Software Expands Plant-Specific Analysis


Pharmaceutical Technology
Volume 38, Issue 2, pp. 12
The Simatic WinCC V7.2 Scada software from Siemens supports the acquisition, visualization, and analysis of production data. Analysis with this new software package is based on the process data acquired by WinCC, which are associated with each other during runtime. The user sets up the calculation formulas to be used in WinCC, without any additional knowledge. Several visualizations are possible for evaluation: a Gantt chart with the time sequence of states, a bar chart for analyzing the key performance indicators, and a table for states and accompanying values. The visualizations are also available via the Web. The calculated key performance indicators can be further processed in a WinCC display, line-dashboard, or in a trend display. In conjunction with the Simatic information server, the key performance indicators can be grouped together online to form target-group-oriented reports and can be queried at any time.

Siemens

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here